1. Home
  2. TMDX vs MTRN Comparison

TMDX vs MTRN Comparison

Compare TMDX & MTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • MTRN
  • Stock Information
  • Founded
  • TMDX 1998
  • MTRN 1931
  • Country
  • TMDX United States
  • MTRN United States
  • Employees
  • TMDX N/A
  • MTRN N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • MTRN Industrial Specialties
  • Sector
  • TMDX Health Care
  • MTRN Industrials
  • Exchange
  • TMDX Nasdaq
  • MTRN Nasdaq
  • Market Cap
  • TMDX 2.3B
  • MTRN 2.1B
  • IPO Year
  • TMDX 2019
  • MTRN N/A
  • Fundamental
  • Price
  • TMDX $111.50
  • MTRN $75.41
  • Analyst Decision
  • TMDX Buy
  • MTRN Buy
  • Analyst Count
  • TMDX 10
  • MTRN 2
  • Target Price
  • TMDX $122.89
  • MTRN $120.00
  • AVG Volume (30 Days)
  • TMDX 1.2M
  • MTRN 141.8K
  • Earning Date
  • TMDX 05-08-2025
  • MTRN 05-01-2025
  • Dividend Yield
  • TMDX N/A
  • MTRN 0.74%
  • EPS Growth
  • TMDX N/A
  • MTRN N/A
  • EPS
  • TMDX 1.41
  • MTRN 0.49
  • Revenue
  • TMDX $488,227,000.00
  • MTRN $1,719,782,000.00
  • Revenue This Year
  • TMDX $25.33
  • MTRN $1.32
  • Revenue Next Year
  • TMDX $20.53
  • MTRN $8.03
  • P/E Ratio
  • TMDX $79.36
  • MTRN $154.17
  • Revenue Growth
  • TMDX 64.43
  • MTRN 6.96
  • 52 Week Low
  • TMDX $55.00
  • MTRN $69.10
  • 52 Week High
  • TMDX $177.37
  • MTRN $123.21
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 78.52
  • MTRN 39.38
  • Support Level
  • TMDX $92.49
  • MTRN $70.94
  • Resistance Level
  • TMDX $95.71
  • MTRN $91.03
  • Average True Range (ATR)
  • TMDX 4.79
  • MTRN 3.36
  • MACD
  • TMDX 0.81
  • MTRN -0.51
  • Stochastic Oscillator
  • TMDX 71.36
  • MTRN 22.25

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About MTRN Materion Corporation

Materion Corp specializes in the development of specialty engineered alloy systems, inorganic chemicals and powders, precious and non-precious metals, beryllium and beryllium composites, and precision filters and optical coatings. The company operates in four reportable segments: Performance Materials, Electronic Materials, Precision Optics, and Others. The majority of revenue is derived from Electronic Materials which produces chemicals, microelectronics packaging, precious metal, non-precious metal, and specialty metal products, including vapor deposition targets, frame lid assemblies, clad and precious metal pre-forms. The Performance Materials segment provides engineered solutions comprised of beryllium and non-beryllium-containing alloy systems and custom-engineered parts.

Share on Social Networks: